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ABSTRACT 
The main goal of the food industry is to provide consumers with fresh, well-preserved, and 
palatable food. In the early 20th century, the food industry was blooming. Yet, many were 
battling to conserve the taste of packed and processed food. MSG came as a perfect solution. 
Today, it stands as the most commonly used flavor enhancer in the food industry. Yet, concerns 
were raised after several incidences of Chinese restaurant syndrome (CRS) emerged. To 
investigate this issue, many short-term human trials and animal studies were conducted. The 
data obtained were ambiguous, inconclusive, and sometimes irrelevant to the human level of 
consumption. In this study, we used zebrafish as an animal model to investigate the effect of 
MSG on development, behavior, and oxidative stress. Embryos were treated with food-grade 
MSG for 4 days with concentrations varying from 50 to 50,000mg/L at two different 
developmental periods.MSG induced growth retardation, mortality, and delayed hatching when 
exposed in the cleavage period at a higher concentration. No change in thigmotaxis and 
oxidative stress were observed in the 3dpf larvae treated with 500mg/L of MSG. Our study 
strongly supports the harmful effect of MSG during early period of development when 
consumed in higher concentration. Thus, we suggest exercising caution in the consumption of 
MSG, especially in children. 
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1.INTRODUCTION 
 1.1 Monosodium Glutamate (MSG) 
Monosodium glutamate is the sodium salt of glutamic acid. It is a crystalline white/off-white 
powder with M.W of 169.112 g/mol. This odorless compound is highly soluble in water and 
insoluble in alcohol and ether. It is the most commonly used flavor enhancer in the food 
industry (1). The Food and Drug Association (FDA) has categorized MSG under “Generally 
Recognized as Safe (GRAS) “list. According to the FDA, its use should be by Good 
Manufacturing Practices (GMP)(2).  
In developed countries, the estimated daily dietary intake of MSG is 0.3-1.0 gram/day. In recent 
years, its excessive and undefined usage in the food industry has raised concerns; mainly due 
to the emerging cases of Chinese Restaurant Syndrome (CRS). The occurrence of CRS is most 
prevalent in countries with the highest level of MSG consumption (3).  
 
   
 
 
Figure 1. Structure of Monosodium Glutamate 
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Figure 2.Food products containing MSG: Knorr soup, Pringles, Cheetos and Maggi 
(clockwise) 
1.2  Oxidative stress 
Oxygen is an essential gas in the living world.  The generation of adenosine triphosphate (ATP) 
takes place through oxidative phosphorylation. Although this process is critical for the 
production of energy, it can cause severe damage to the structural integrity of the cell by 
forming reactive oxygen species (ROS). Hence, the body is under a constant attack by this 
malicious oxygen. In order to prevent damage, the cell has evolved with a system of antioxidant 
mechanisms that nullifies the harmful effects of reactive species. Any perturbation to this 
balance can lead to a state called oxidative stress (4). Neurological pathologies and disorders 
such as schizophrenia, Autism Spectrum Disorder (ASD), Amyotrophic Lateral Sclerosis 
(ALS), depression, and anxiety are associated with oxidative stress (5–9). 
1.3 Anxiety 
Anxiety is a state of mind wherein the subject presumes danger/fear without its actual 
existence. Occasional anxiety is reasonable and sometimes necessary for flight /fight response. 
It becomes a disorder when without any real occurrence of danger; a persistent feeling of 
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disturbance, turmoil, worry, and confusion exists. There are different types of anxiety, such as 
existential, social, trait-based,  test/performance, choice/decision making, and generalized. The 
most common symptoms include rapid heartbeat, profuse sweating, confusion, irritability, 
restlessness, and sleeplessness. Most of the patients facing anxiety are victims of a troubled 
childhood, sexual/physical/substance abuse, and trauma. It can also have a genetic base (10). 
1.4 Zebrafish as an animal model 
Zebrafish are widely used animal model due to their small size, low cost, easy maintenance, 
external fertilization, high fecundity, and transparent embryos. Researchers use this model 
extensively for toxicological profiling of commonly used preservatives, drugs, flavor enhancer, 
and pesticides. With the advancement in the imaging and labeling techniques, these transparent 
larvae can provide critical insight at the systemic, organ, cellular, and sub-cellular levels. Due 
to external fertilization, early developmental defects and changes can be easily captured with 
precision. Behavioral assay to study condition like anxiety is well-developed in this model. 
Hence, we used zebrafish larvae to study developmental, behavioral, and oxidative changes 
due to MSG.  
 
                                                  
 
                             
Figure 3. Zebrafish larvae as a model organism: Panel A) Representative image of a 24 hpf 
embryo; Panel B) Representative image of a 48 hpf larva; Panel C) Representative image of a 
72 hpf larva Panel D) Representative image of a 96 hpf larva 
 
A
 
 
B
 
 
C
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Figure 4: Mature adult zebrafish (90 days – 2years) 
2.REVIEW OF LITERATURE 
2.1 Effect on MSG 
2.1.1 Human studies 
In the late 20th century, studies on the usage of MSG accelerated due to increasing cases of 
palpitation, flushing, headaches, restlessness, muscle tightness, and tingling/numbness after 
consumption of Chinese food. This condition of hypersensitivity to Chinese food is called 
“Chinese restaurant syndrome.” A table of different case studies and human trials on MSG and 
its safety enlisted as below: 
2.1.1.1 Case studies 
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Table 1.Case studies are showing the adverse effects of MSG. 
Case study Conclusion References 
1.Four female with fibromyalgia (for 2 to 17 
years) (11) 
Fibromyalgia symptoms reduced with the 
cessation of MSG in the diet. Consumption of 
MSG caused the reoccurrence of symptoms 
(11). 
Smith et al. Ann Pharmacother. 2001 
Jun;35(6):702-6. 
  
2.A 7 months old infant developed granuloma 
after BCG injection (12). 
Monosodium glutamate (used as a 
carrier/stabilizer) in the BCG vaccine caused 
foreign body granuloma (12). 
Chiu et al.  J Am Acad Dermatol. 2006 
Aug;55(2 Suppl):S1-5. 
3.A 15-year-old white girl is showing orofacial 
granulomatosis on the consumption of MSG 
(13). 
Allergic reaction to MSG.MSG-restricted diet 
lead to resolution of the facial swelling (13). 
Oliver et al.  Oral Surg Oral Med Oral 
Pathol. 1991 May;71(5):560-4 
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2.1.1.2 Human trials: 
Table 2.Human trials and their conclusion on the effects of MSG 
Aim of the study Study design Conclusion References 
1.To evaluate the reaction to MSG 
using a multiphase, multicenter, 
double-blinded placebo-
controlled crossover study 
design(14). 
130 MSG-sensitive volunteers 
participated. Challenge A: 5g 
MSG without food; Challenge B 
(to evaluate reproducibility and 
consistency): Individuals who 
responded in challenge A were 
rechallenged again with 5g of 
MSG and placebo; Challenge C: 
Rechallenged the individuals who 
responded to both the previous 
challenges (only MSG 
responders); Challenge D: MSG 
responders in challenge C were 
rechallenged thrice with food 
(14). 
Large doses of MSG consumed 
without food can elicit CRS 
symptoms. Responses were 
neither severe nor consistent (14). 
Geha RS et al. J Allergy Clin 
Immunol. 2000 Nov;106(5):973-
80. 
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2. To determine whether MSG 
can induce bronchoconstriction in 
asthma patients who claim to be 
MSG-intolerant (15). 
In this study, twelve subjects with 
asthma and claims of being MSG-
intolerant participated. 
Challenged with 1g of MSG (day 
1), 5g of MSG (day 2) and 5g of 
lactose (placebo-day3) in the 
morning after overnight fasting. 
At the end of three days, 
nonspecific bronchial 
hyperresponsiveness was 
measured. FEV1 and peak 
expiratory flow rate evaluated for 
all control and challenge days. 
Soluble inflammatory marker 
activity was determined (15). 
This study concluded that MSG 
does not induce asthma (15). 
Woods RK et al. J Allergy Clin 
Immunol. 1998 Jun;101(6 Pt 
1):762-71. 
3. To study the short-term 
neuroendocrine effect of a hefty 
dose of MSG on fasting males 
(16). 
Fasting males challenged for four 
days with 12.7g MSG on day 1, an 
MSG vehicle on day 2, an IV 
injection of TRH on day 3 and a 
high protein diet on day 4 (16). 
High plasma level of glutamate 
causes a minimal effect (if any) on 
hypothalamic and pituitary 
function (16). 
Fernstrom JD et al. J Clin 
Endocrinol Metab. 1996 
Jan;81(1):184-91. 
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4. To study the CRS symptoms in 
self-identified MSG sensitive 
subjects (17). 
No. of participants= 61. Type of 
study= Double-blinded and 
placebo-controlled. Challenge 1:  
5g of MSG and placebo given to 
the subjects in a double-blind way. 
Challenge 2: Positive responders 
to the             test chemical 
rechallenged with 1.25, 2.5, 5 g of 
MSG, and placebo (17). 
In this study, MSG-sensitive 
subjects showed CRS symptoms 
in a statistically higher rate 
compared to the placebo group 
(17). 
Yang WH et al. J Allergy Clin 
Immunol. 1997 Jun;99(6 Pt 
1):757-62. 
5. To study whether MSG causes 
flushing (18). 
Flushing in six subjects was 
studied using laser Doppler 
velocimeter to monitor changes in 
facial cutaneous blood flow after 
challenge with MSG and 
pyroglutamate (18). 
MSG can rarely (if any) provoke 
flushing (18). 
Wilkins JK. J Am Acad 
Dermatol. 1986 Aug;15(2 Pt 
1):225-30 
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These pioneering studies focused on studying the physiological effect of MSG rather than 
behavioral effects. No studies are available that relates MSG and anxiety in human subjects. 
2.1.2 Animal models 
2.1.2.1 In Mice 
Among the pioneering studies on the effect of MSG in mice, Olney JW observed severe brain 
lesions (intracellular edema and neuronal necrosis) in newborn mice when given a 
subcutaneous injection of 0.5 to 4 mg/g  (19). In one study, Kunming filial mice treated with 
MSG (2.5mg/g or 4mg/g) at 17-21 day of pregnancy, gave birth to offsprings that showed 
impaired Y-maze discrimination learning (at 60 days) without visible damage to the 
hypothalamus area (20). Recently, a group of scientists observed an increase in the depression-
like condition in young mice (4 to 5 weeks old) treated with 2.5g/kg of MSG. Also, such a 
depressive condition was observed even in treated adults (9 to 10 weeks)  at a higher rate than 
the healthy controls (21). 
2.1.2.2 In Rats 
Palaez et al. observed neural necrosis in hypothalamic arcuate nuclei of neonatal rats (22). In 
another study, a 4mg/g subcutaneous injection of MSG given at postnatal day 2,4,6, 8 and 10, 
reported a reduction in the pituitary weight by 30% and 40% at the age of 6 and 12 months 
respectively(23). Using the same dose of MSG at postnatal day 1,3,5, and 7,  González-Burgos 
et al. observed severe damage to the prefrontal cerebral cortex (24).  One study linked 
physiological changes in the brain to changes in the behavior of neonatal rats. This group of 
researchers found that with an increase in the level of glutamate and catecholamines in the 
brain tissue, there was a  decrease in spatial memory and learning (25).  A recent study on male 
albino rats has reported a significant reduction in cognitive functions even at a low dose of 1/20 
of LD50 given through gavage(26). Apart from its effect on the CNS, many studies have shown 
that MSG causes obesity and other metabolic disorders (27–29).At a dose of 4mg/g of MSG, 
the levels of testosterone and size of the testes in sexually matured rats were found to be lower 
than the controls (30). 
 
2.1.2.3 In Zebrafish 
In the past few years, MSG toxicity studies on zebrafish have gained impetus.  One study 
published in the year 2016, observed severe abnormalities like yolk and pericardial edema, lack 
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of pigmentation, tail bending and scoliosis along with developmental defects such as growth 
retardation at a concentration of 100  to 500mg/L (31). A year later, another group found the 
LC50 of MSG to be 15,200 ppm and 10,300 ppm in 48hpf and 96hpf embryos, respectively. 
The same study observed cardiotoxicity at a low concentration of 15ppm, developmental 
malformation at 150ppm, and sublethal effects at 1,500ppm (32). Kurnianingsih et al. treated 
embryos with 10µg/ml of MSG and observed increased apoptosis in brain tissue and a decrease 
in locomotor activity. They concluded that at the early developmental stage,  MSG could 
increase the risk of brain damage and chances of stereotypic behavior (33). 
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2.2 MSG and oxidative stress 
Table 3.Studies showing the relationship between MSG and oxidative stress 
Aim of the study Study design Conclusion References 
1.To study the effect of MSG on 
hepatic microsomal lipid 
peroxidation, calcium, ascorbic 
acid, glutathione, and its 
dependent enzyme in adults male 
mice (34). 
Subcutaneously injected 4mg/g of 
MSG in adult male rats for six 
days (34). 
Increase in lipid peroxidation in 
the hepatic microsomes. The level 
of glutathione (GSH) significantly 
reduced. An increase in the 
activity of glutathione-related 
enzymes such as GST, GR, GPX 
was found (34). 
Choudhary et al. Toxicology 
Letters. Volume 89, Issue 
1, December 1996, Pages 71-76 
  
2. To study the effect of Vitamin E 
on MSG-induced hepatoxicity and 
oxidative stress in rats (35) 
A dose of 0.6mg/g was given 
through gavage for 10 days to rats 
(35). 
Significant increase in the level of 
lipid peroxidation, decrease in 
glutathione (GSH) with the 
increased enzymatic activity of 
glutathione-s-transferase (GST), 
catalase and superoxide dismutase 
(SOD)  was observed in the liver 
(35). 
Onyema et al. Indian Journal of 
Biochemistry and Biophysics. 
Volume 43, Issue 1, February 
2006, Pages 20-24. 
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3. To study the effect of Vitamin 
C, Vitamin E and quercetin on 
oxidative damage and 
genotoxicity caused due to MSG 
in the rat model (36) 
4mg/g of MSG given 
intraperitoneally for 10 days. The 
treatment group was given 
additional 200mg/kg of Vitamin C 
in saline solution, 200mg/kg of 
Vitamin E in corn oil and 10mg/kg 
of quercetin in corn oil along with 
MSG (36).  
MDA (a biomarker for lipid 
peroxidation) remarkedly 
increased in the liver, kidney and 
brain tissue. The decrease in GSH, 
increased activity of GST, SOD, 
and CAT were observed. Vit E, 
Vit C, and quercetin successfully 
recovered different tissues (brain, 
kidney, and liver) from the 
oxidative stress (36). 
 .Human and Experimental 
Toxicology.  Volume 25, Issue 5, 
May 2006, Pages 251-259 
4. The effect of dietary 
administration of MSG on lipid 
peroxidation and antioxidant 
status in the brain was studied 
(37). 
For 14 weeks, mice were fed (30% 
w/w) MSG containing diet (37). 
The dietary consumption of MSG 
in large quantities increases the 
weight of cerebrum with a 
corresponding increase in lipid 
peroxidation and reduction in 
CAT activity (37). 
Adebayo et al. Asian Journal of 
Clinical Nutrition. Volume 3, 
Issue 2, 2011, Pages 71-77 
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2.3 MSG and anxiety 
Table 4.Studies showing the role of MSG in causing anxiety 
Aim of the study Study design Conclusion References 
1.To investigate whether MSG 
causes depression-like condition 
and anxiety in young rats (38). 
Male and female Wistar rats 
received a subcutaneous injection 
of 4g/kg/day during 1st to the 5th 
postnatal period. The behavioral 
test was performed on 60th to 64th 
postnatal day (38). 
Due to a dysfunction in the 
serotonergic system, MSG-treated 
rats are more susceptible to 
develop anxiogenic and 
depression-like behavior (38). 
Quines et al. Life Sciences. 
Volume 107, Issues 1–2, 27 June 
2014, Pages 27-31. 
 
2. To study the effect of 
monosodium glutamate and 
aspartame on behavioral and 
biochemical parameters of male 
albino mice (39). 
The dose of MSG: 8mg/g. Mode 
of administration: Oral (in 
drinking water). Duration of 
treatment: One month.  Anxiety 
test: The elevated plus-maze with 
two open and two closed arms 
(39) 
Both MSG and aspartame 
(individually and combined) 
showed an increase in anxiety and 
fear (39). 
 
Abu - Taweel, Gasem. (2016). 
African Journal of Biotechnology. 
15. 601-612. 
10.5897/AJB2015.15199. 
3.To study the effect of commonly 
used flavor enhancer on the 
behavior of mice when given 
orally (40). 
      
Mice received an oral dose of 
10mg/kg of MSG for 21 days. One 
group of control and pretreated 
mice (n=20) were allotted for the 
open-field test (OFT) and another 
At the dose used in the study, it 
was concluded that MSG was 
associated with anxiety-related 
behavior (40). 
Onaolapo, O.J., Aremu, O.S. & 
Onaolapo, A.Y. Naunyn-
Schmiedeberg's Arch Pharmacol 
(2017) 390: 677. 
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group for elevated plus maze 
(EPM) test. OF and EPM tests 
were performed on day 1 and 
21(40). 
https://doi.org/10.1007/s00210-
017-1371-6 
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3.SCOPE OF THE STUDY 
3.1 Aim 
Due to different study designs and animal models, the data on the effects of MSG is still 
inconclusive and biased. In this project, we did a dose-dependent toxicity study to observe the 
effect of MSG on zebrafish larvae when the larvae were exposed to MSG at two different 
developmental periods.  In additional, we investigated whether MSG elicits anxiety-like 
behavior and oxidative stress in this model organism. 
3.2 Objectives 
• To analyze the differences in the %abnormalities, mortality rate, and hatching rate in 
zebrafish embryos, when the exposure to the larvae was initiated at two different 
developmental periods namely cleavage and blastula. 
• To find whether MSG induces anxiety-like behavior. 
• To study the effect of MSG on oxidative stress. 
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4.MATERIALS AND METHODS 
4.1 Zebrafish housing 
Adult female and male fish were purchased from a local supplier and maintained in 10L and 6 
L tanks filled with RO water. All the fish were acclimatized to laboratory condition for two 
weeks before using them for experiments. The temperature (26ºC ± 2) and oxygen levels were 
maintained using a heater and aerator, respectively. E3 media (0.0595M NaCl, 0.021M KCl, 
0.039M CaCl2.2H2O and 0.048M MgCl2.6H2O: pH 7.2, sterile) was added to each tank to 
maintain the total dissolved solids (TDS) concentration. The fish were fed with pelleted diet 
twice daily. Cleaning of the tanks took place on every alternate day. 
4.2 Zebrafish mating and collection of embryos 
Our laboratory uses a breeding chamber to facilitate spawning and mating of female and male 
fish. This breeding chamber is made up of two containers: one with mesh-like openings at the 
bottom that fits onto the second container. The mesh-like design prevents adult fish from 
eating/damaging the embryos by collecting them efficiently in the second container. Healthy 
adult fish in the ratio of 2 females to 1 male is kept in the dark condition for 12 hrs ; followed 
by 1 hr of light condition on the next day. The embryos are produced during the light condition 
and are collected in a 90mm petri dish using Pasteur pipette (1 ml). They are washed thrice 
with RO water and then stored in E3 media. The petri dish is kept in a BOD incubator with 
appropriate labeling until use. 
 
 
Figure 5.Setup of a breeding tank. 
 
Adult Male Adult females 
Artificial plants to stimulate spawning 
Mesh-like design 
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4.3 Preparation of MSG solution   
MSG was purchased from a local spice shop. The product is a registered trademark owned and 
licensed by AJINOMOTO CO., INC.TOKYO, JAPAN. This company is the first one to 
produce AJI-NO-MOTO commercially. 
 
Figure 6. Food-grade MSG used for the study 
4.3.1 Preparation of the stock solution 
Total volume prepared=100ml 
1. Stock concentration =100,000 mg /L 
Dissolved 10 grams of food grade MSG in 100 ml of RO water. 
2. Stock concentration=1000mg/L 
Dissolved 0.1 grams of food grade MSG in 100 ml of RO water. 
4.3.2 Preparation of the working solution 
Total volume= 10ml 
Table 5. Preparation of working concentration 
Dose Volume added from a 
stock solution (in ml) 
The volume of E3 
media added (in ml) 
50 0.5 9.5 
500 5 5 
5000 0.5 9.5 
50,000 5 5 
 
Stock 
concentration: 
1000mg/L 
Stock 
concentration: 
100,000mg/L 
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Embryos in E3 media is the control for all experiments. 
4.4 Treatment with MSG 
Group 1 (Developmental period: Cleavage): Incubation time before treatment= 1.5 to 2 Hrs  
Group 2 (Developmental period: End of Blastula): Incubation time before treatment = 5 hrs  
After the respective time of incubation, the embryos were taken from the BOD incubator and 
placed in a 24-well plate with a per well density of 10 embryos. All the treatment wells were 
washed with appropriate working solution after removing all the E3 media. 1.5- 2ml of E3 
media and the working solution was added to the control and treatment group, respectively. 
Every 24 hrs, all the solutions were replaced with a freshly-prepared solution. Every day, 
embryos in all the well were analyzed individually for mortality, hatching, and abnormality. 
4.5 Hatching and mortality rate 
Hatching is an important developmental process wherein the embryo comes out of the chorion 
layer and becomes a larva. The hatching rate was measured at different time points of 36 hrs,44 
hrs, 48 hrs, and 72 hrs.  
 
Hatching rate= No. of hatched embryos (cumulative)  × 100 
 
Mortality in zebrafish embryos is characterized by  
1. Coagulation 
2. Lack of somite formation 
3. Non-detachment of the tail 
4. Lack/End of heartbeat. 
Embryos showing all or any one of the characteristics as mentioned above were considered 
dead. The mortality rate was calculated for every 24 hrs upto 96hrs. 
Mortality rate= No. of embryos dead (cumulative)   ×   100 
 
 
Total no. of live embryos 
Total no. of embryos present at the 
start of the experiment 
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4.6 Imaging of the embryos 
All the embryos and larvae were individually observed under an inverted bright field 
microscope, Olympus lX73 series with a resolution of 1280×720 (bin) and 800×600 
respectively; using a 4X objective. Procam HS-10 MP camera was used to capture images from 
the microscope. 
4.7 Thigmotactic activity 
Thigmotaxis is the preference of edge/ walls. Three days old (72 hours post-treatment) treated 
embryos (Group I: Incubation time before treatment= 2hrs) in 500mg/L of MSG solution and 
control embryos in E3 media are used for this experiment. First, all the embryos from both the 
control and treated group were monitored under the microscope, and any embryos showing 
morphological abnormality were excluded from this experiment. Using a Pasteur pipette, one 
larva was dropped in the center of a well of the 24-well plate containing 500µl of E3 media. 
Videos are recorded using a digital camera to track the movement and orientation of each larva 
(from the control and treatment group) for 30sec. The preference of edge/walls is an indication 
of anxiety in zebrafish larvae. 
 
%Thigmotaxis= No. of larvae that moved towards the walls × 100 
 
 
4.8 Measurement of oxidative stress using DCFDA ROS assay 
4.8.1 Preparation of the solutions 
1. 5µM of DCFDA solution: 
The total volume prepared for one experiment= 4ml 
The volume of DCFDA solution taken from 2mM stock solution= 10µl 
Volume of E3 media added= 3990µl 
2. 200mg/L of tricaine solution (for immobilizing the larvae): 
The total volume prepared for one experiment =1ml 
The volume of tricaine solution taken from the 4000mg/L stock solution= 50µl 
Total no. of larvae in particular group 
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Volume of E3 media added= 950µl 
4.8.2 Procedure 
1. Placed 10 embryos/well from control and treatment in a 24 wells-plate (covered 
completely with aluminum foil).  
2. The light was turned off before taking out the DCFDA solution. 
3. The solution in the wells was replaced with 1ml of 5µM of DCFDA solution. 
4. The plate was incubated for 30mins in BOD incubator. 
5. After 30 mins, all the DCFDA solution was carefully removed, and the embryos were 
washed with 1ml of E3 media twice at an interval of 5mins. 
6. After the second wash, new E3 media was added, and each embryo was placed on a 
slide (one at a time) for observation under the microscope.  
7. Procam software was used to capture images at a resolution of 3366×1222 with a 4X 
objective and a fluorescence filter 2 (green filter). The exposure time was set at 120ms. 
Duration of exposure was 2mins. Both bright field and fluorescent images were taken 
at the start and end of 2mins. All the measurements for control and the treated group 
were done under the same condition. 
8. Fluorescence was quantified with Image J software as described below 
4.9 Fluorescence quantification using Image J 
1. The images captured after oxidative stress experiment are opened in Image J 
software. 
2. A duplicate of this image was made, and the original image was closed. The 
duplicate image was converted to 8-bit type using Image 
3. In the Analyze tab, Set Measurement option was chosen, and Mean, Maximum, 
Minimum and Integrate density options were selected. 
4. After this, the Measure option from the Analyze tab was selected. 
5. The results were displayed in another window. Note that the minimum and 
maximum value displayed in the result are 0 and 255, respectively. If not, the 
following steps were followed: Process 
6. Change the formula displayed to 
Vnew (min)= (V)- (Vmin) 
Vnew (max)= (V)* (255/Vmax) 
 Type 8-bit  
Math Macro 
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Enter the value of Vmin and Vmax as displayed in the result table. 
7. A re-measurement was done to ensure the New minimum and maximum value are 
set to 0 and 255, respectively. 
8. In the Image tab, from the Adjust option, Threshold was selected. In the threshold 
dialog box, the Intermode option was selected. The upper limit for threshold was 
set at 255, whereas the lower limit was set according to the experimenter’s 
discretion. (NOTE: Use the same upper and lower limit threshold for both control 
and treatment) 
9. These changes were applied. The highlighted area was selected using the magic 
wand tool. The area and intensity were measured using the Measure option from the 
Analyze tab. The calculated area and intensity were displayed in the result window. 
These data were noted for statistical analysis. 
4.10 Statistics 
All dose-response, anxiety, and oxidative stress experiments were performed twice 
independently. All data were analyzed using GraphPad Prism version 5. For dose-response 
experiments, statistical analysis was done using one-way ANOVA test followed by Dunes post-
test. Column statistics (Mean, SEM, SD) were calculated for statistical analysis of anxiety and 
oxidative stress data. All data are presented as mean± SEM for the indicated n numbers.  
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5. RESULTS: 
5.1 Group I: Treatment started after 2 hrs of incubation  
At 2 hrs post fertilization, the zebrafish embryos are at 2-64 cells stage of development (41). 
Before the start of treatment, the embryos were observed individually under the microscope. 
Only 2-64 cells stage embryos (shown in Fig 2.) were collected and distributed at random into 
the control and treatment group. 
 
Figure 7.Different stages in the Cleavage period 
5.2 Group II: Treatment started after 5 hrs of incubation 
At 5 hours post fertilization, the zebrafish embryos are in the latter half of the blastula 
period(41). Healthy larvae were selected under the microscope and randomly distributed into 
control and treatment group.  
Control group:                    Placed in E3 media 
Treatment group:               50, 500, 5000 and 50,000mg/L of MSG 
Duration of experiment:     4 days 
Parameters studied:             Mortality rate, hatching rate, and % abnormality. 
 
Figure 8.Embryos in the blastula period 
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5.3 Effect of MSG on the mortality rate 
The mortality rate was measured every 24 hrs for 4 days in control as well as 50, 500, 5000, 
and 50,000 mg/L MSG-treated group. At a concentration of 50,000mg/L of MSG, all embryos 
in both group I and II show 100% mortality on day 1 (Fig.9A and 10A). Apart from this 
concentration, no mortality is observed in any concentration at any time point in group II 
(Fig.10). Compared to group II, the mortality rate in group I at 24 hrs for 500mg/L and 
5000mg/L is 12.07%±12.07%and 12.38% ±9.045% higher respectively (Fig.11A).  Mortality 
rate increased by 7.14% at 48 hrs for 5000mg/L in group I. Mortality was observed only till 48 
hrs in group I (Fig.9B). No change in mortality was observed in any group at 72 and 96 hrs 
post-treatment (Fig.11C and 11D). 
5.3.1 Effect of MSG on the mortality rate of embryos in group I 
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Figure 9.Effect of MSG on the mortality rate of embryos in group I: Four time points were 
selected, and mortality rates were plotted for control, 50mg/L, 500mg/L, 5000mg/L and 
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50,000mg/L MSG-treated group at A) 24 B) 48 C)72 D) 96 hours post-treatment. Data is 
represented as mean± SEM for 58-60 embryos in each group. 
5.3.2 Effect of MSG on the mortality rate of embryos in group II 
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Mortality at 72 Hrs
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Figure 10.Effect of MSG on the mortality rate of embryos in group II: Four time points 
were selected, and mortality rates were plotted for control and MSG-treated group at A) 24 B) 
48 C)72 D) 96 hours post-treatment. Data is represented as mean± SEM for 30 -70 embryos in 
each group. 
5.3.3 Comparison of mortality rates from the group I and II 
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Mortality rate at 24 Hrs (Comparative)
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Figure 11.Comparison of mortality rates from the group I and II: Four time points were 
selected, and mortality rates from the group I and II were plotted together for control and MSG-
treated group at A) 24 B) 48 C)72 D) 96 hours post-treatment. Data is represented as mean± 
SEM for 58-60 and 30 - 70 embryos in group I and II respectively. 
 
5.4 Effect of MSG on hatching rate 
Hatching marks a crucial developmental process in the zebrafish life cycle. It is characterized 
by the shedding of the outer layer called the chorion. Hatching was observed at different times 
points: 36 , 44 , 48, and 72 hrs. post-treatment for both the group I and II. No hatching in any 
group was observed at 36 hrs post-treatment. Hence, all the graphs are plotted, considering 
only three time points. As depicted in Fig.14, the hatching in group I embryos were delayed 
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compared to the hatching in group II embryos. In 5000mg/L concentration of group I, 30% of 
the embryos did not hatch even at 72 hrs post-treatment (Fig. 12C).  In our lab, most of the 
embryos hatch by 48 hrs. In group II, the hatching rate at 48 hrs for control, 50, 500 and 5,000 
mg/L of MSG is 95%±5,  89.59%±2.915,   95%±5 and 95%±5 respectively, whereas for group 
I, the corresponding values are 86.21%±13.80, 68.29%±7.575,   71.81%±10.95 and  
24.05%±17.36 (Fig.12A-D and 13A-D). This data clearly shows that MSG induces delayed 
hatching when exposed during early stages of development at higher concentration. 
5.4.1 Effect of MSG on hatching rate of embryos in group I 
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Figure 12.Effect of MSG on hatching rate of embryos in group I: Three time points were 
selected, and hatching rates were plotted for control, 50mg/L, 500mg/L and 5000mg/L MSG-
treated group at A) 44 B) 48 C)72 hours post-treatment. Data is represented as mean± SEM for 
58-60 embryos in each group. 
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5.4.2 Effect of MSG on hatching rate of embryos in group II 
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Figure 13.Effect of MSG on hatching rate of embryos in group II: Panel (A-C) represents 
three time points of 44, 48- and 72-hours post-treatment hatching rates plotted for control, 
50mg/L, 500mg/L, and 5000mg/L MSG-treated group. Data is represented as mean± SEM for 
30-70 embryos in each group. 
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5.4.3 Comparison of hatching rates from the group I and II 
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Figure 14.Comparison of hatching rates of group I and II: Three time points were selected 
and hatching rates of the group I and II were plotted together for control and MSG-treated 
group at A) 44 B) 48 C)72 hours post-treatment. Data is represented as mean± SEM for 58-60 
and 30 - 70 embryos in group I and II respectively. 
5.5 MSG and morphological abnormality in zebrafish embryos 
For 4 days, daily, all the embryos were observed individually for morphological abnormalities, 
and their images were captured. With an increase in the MSG concentration from 500 to 
5000mg/L in group I, the % abnormality increased from 9.09%±9.09 to 65.52%±34.39 
(Fig.15A). Group II larvae displayed no signs of abnormality at any concentration, at any time 
point (Fig.16A-D). MSG induces abnormality in zebrafish larvae when exposed at an early 
developmental stage and at higher concentrations (Fig.17). The only abnormality observed in 
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this study was growth retardation (Fig.15D and 15E). A latency in hatching is observed at 
5000mg/L concentration, which can be due to a higher number of growth-retarded embryos. 
5.5.1 Effect of MSG on the morphology of embryos in group I 
In group I, an abnormality was observed only on day 1. Hence, all the data on % abnormality 
is restricted to 24 hrs post-treatment embryos.  
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Figure 15.Effect of MSG on the morphology of embryos in group I: Abnormalities were 
quantified, and % abnormality data was plotted for control and treatment group at A) 24 hours 
post-treatment.  Panel B) Representative image of control larvae; Panel C) Representative 
image of 50mg/L MSG-treated larvae; Panel D) Representative image of 500mg/L MSG-
treated larvae Panel E) Representative image of 5000mg/L MSG-treated larvae. Data is 
represented as mean± SEM for 58-60 embryos in each group. 
5.5.2 Effect of MSG on the morphology of embryos in group II 
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No morphological abnormality was observed in the group II embryos throughout the 
treatment period at any concentration.  
 
    
Figure 16.Effect of MSG on the morphology of embryos in group II: Panel A) 
Representative image of control larvae; Panel B) Representative image of 50mg/L MSG-
treated larvae; Panel C) Representative image of 500mg/L MSG-treated larvae Panel D) 
Representative image of 5000mg/L MSG-treated larvae. All the representative images are 
captured at 24hrs post-treatment. 
5.5.3 Comparison of %Abnormality data from the group I and II 
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Figure 17.Comparison of %Abnormality data from the group I and II: % Abnormality 
data from the group I and II were plotted together for control and MSG-treated group at 24 
hours post-treatment. Data is represented as mean± SEM for 58-60 and 30 - 70 embryos in 
group I and II respectively. 
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5.6 MSG and anxiety 
Due to several reports claiming the involvement of MSG in inducing anxiety-like behavior, I 
performed a behavioral assay to assess anxiety in MSG-treated zebrafish embryos. 
Thigmotaxis is an indicator of anxiety-like behavior wherein the zebrafish larvae depicts a 
preference of edge/wall. 500 mg/L of MSG was the concentration of choice due to its relevance 
with the quantities consumed by humans. Also, this was the concentration of MSG in which 
morphological abnormality was first observed. Thigmotaxis was recorded on day 3 for control 
and 500 mg/L MSG-treated group. The incubation time before the start of treatment for this 
study was 2 hrs. The % thigmotaxis in control and 500mg/L MSG-treated group is 
34.23%±4.230 and 37.50%±2.5, respectively (Fig.18). MSG did not induce anxiety in 
zebrafish larvae. 
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Figure 18.Effect of MSG on thigmotactic behavior of zebrafish larvae: % Thigmotaxis was 
quantified in control and 500mg/L MSG-treated group I larvae at 72 hours post-treatment. Data 
is represented as mean± SEM for 50 embryos. 
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5.7 MSG and oxidative stress 
DCFDA ROS assay was used to measure oxidative stress in 3-days old control and treated 
larvae. After performing the thigmotaxis experiment, few larvae from control and 500mg/L 
MSG-treated group were randomly selected for oxidative stress measurement. Before the start 
of this experiment, the larvae were again observed under a microscope, and the ones with 
abnormality were excluded. The calculated fluorescence intensity is 605548 (a.u) ± 107589 
and 569844 (a.u) ± 142510 for control and treated larvae respectively (Fig.19). Hence, the level 
of oxidative stress induced in control and treated embryos are comparably similar. This data 
indicates that MSG does not induce oxidative stress at a concentration of 500mg/L MSG in 
zebrafish larvae. 
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Figure 19.Effect of MSG on oxidative stress in zebrafish larvae: % Fluorescence intensity 
was quantified and plotted for control and 500mg/L MSG-treated group I larvae at 72 hours 
post-treatment. Data is represented as mean± SEM for 18 embryos. 
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DISCUSSION 
Monosodium glutamate is a widely-used sodium salt of naturally occurring amino acid called 
glutamic acid. It is used abundantly and routinely as a flavor enhancer by the food industry (1). 
Though listed under the category of GRAS by the FDA, its increasingly undefined use in many 
food products might exceed the acceptable daily intake levels (3) . Studies were done to 
evaluate its safety using different animal models (21,23,24,26,31,33). Still, the data remains 
inconclusive and biased due to different study design using irrelevant concentrations. Apart 
from this, the mammalian models fail to provide insight into the critical developmental periods 
due to internal fertilization.  This urged us to investigated the effect of MSG using zebrafish as 
an animal model. With reference to the OECD guidelines for Fish Embryo Acute Toxicity test 
(FET) (42) ;  the hatching rate, mortality rate, and % abnormality were monitored in every 
24hrs for a period of 4 days using appropriate control and 4 different treatment concentrations 
.  
The treatment was initiated at two different developmental periods (Cleavage and Blastula) to 
study the temporal effect of MSG. The cleavage period in characterized by the rapid cell 
division to form an array of blastomeres. These blastomere undergo rapid cell rearrangements 
in the blastula period (41).   Early start of MSG-treatment (i.e., at the time of cleavage) showed 
severe growth retardation at concentrations of 500mg/L and 5000mg/L (Fig. 15A).  This data 
on MSG causing morphological abnormality in zebrafish larvae contradicts the study 
conducted by  Mahaliyana AS et al. (31) who reported morphological abnormality at a low 
dose of 100mg/L. They observed a lack of pigmentation, growth retardation, scoliosis, yolk sac 
and pericardial edema at a concentration of 100-500mg/L in embryos and larvae. We speculate 
that this discrepancy in the data can be attributed to the different genotype of the fish, study 
design, and source of MSG. Most of the studies reporting toxicity has used laboratory-grade 
MSG, which though 99% pure, contain 1% of undefined impurities. Unlike food-grade 
products, these lab-produced chemicals do not undergo rigorous testing for undefined and 
harmful impurities like heavy metals. The product information sheet of L-Glutamic acid 
monosodium salt hydrate (Sigma-Aldrich, Cas number: 142-47-2) used in many studies clearly 
states that the product is not suitable for household or consumption purposes (43). Hence, it is 
critical in the study of this kind to carefully chose an appropriate food-grade source.  
At 48hrs post-treatment, a delay in hatching was observed in embryos at 5000mg/L in group I 
(Fig. 12B). This delay in hatching could be correlated to the data on growth retardation as the 
embryos showing growth retardation took longer to develop and hatch. 
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The embryos treated at cleavage stage showed increased mortality rates compared to those 
treated at the blastula stage (Fig. 11). On the 3rd and 4th day of treatment, no mortality was 
observed in any group (Fig. 11C and 11D) indicating that the toxic effect of MSG is restricted 
to the early days of development when exposed at cleavage period in zebrafish. The mechanism 
behind this early period toxicity needs further investigation. 
Previous studies on rodents have shown that MSG can induce anxiety-like behavior and other 
behavioral alterations (38–40). This prompted us to investigate if MSG can induce anxiety-like 
behavior in zebrafish. This has never been reported before. We did not observe any anxiety-
like behavior induced in zebrafish larvae upon treatment with 500mg/L MSG after 3 days of 
treatment (measured in terms of % thigmotaxis) (Fig.18). To the best of our knowledge, this is 
the first behavioral study to analyze anxiety-like behavior in zebrafish larvae treated with MSG. 
Many previous studies using rodent models have indicated that MSG can induce oxidative 
stress(34–36) and since anxiety and oxidative stress are related (44) , we wanted to know if 
MSG can also induce oxidative stress in zebrafish embryos without affecting their anxiety 
behavior. No significant induction of oxidative stress was observed upon treatment of larvae 
with MSG (Fig.19).  
In summary, this study shows that the toxic effect of MSG is restricted to the early periods of 
development, particularly cleavage, and its effect can be seen in a dose-dependent manner. This 
study suggests caution in the consumption of high quantities of MSG-containing food; 
especially by children. At a relevant concentration of human consumption, food-grade MSG 
does not elicit anxiety-like behavior and oxidative stress in zebrafish larvae. 
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